COVID-19 antibodies on trial

With the first readouts of trials of antibodies against COVID-19 appearing and others coming thick and fast, Nature Biotechnology asked a group of experts to comment on the challenges and timelines for these products.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature biotechnology 2020-11, Vol.38 (11), p.1242-1252
1. Verfasser:	DeFrancesco, Laura
Format:	Artikel
Sprache:	eng
Schlagworte:	Agriculture Antibodies Antibodies - immunology Antibodies - therapeutic use Betacoronavirus - immunology Betacoronavirus - pathogenicity Bioinformatics Biomedical and Life Sciences Biomedical Engineering/Biotechnology Biomedicine Biotechnology Coronavirus Infections - immunology Coronavirus Infections - therapy Coronavirus Infections - virology Coronaviruses COVID-19 Humans Life Sciences Monoclonal antibodies Pandemics Pharmaceutical industry Pneumonia, Viral - immunology Pneumonia, Viral - therapy Pneumonia, Viral - virology Product development Q&A q-and-a SARS-CoV-2 Testing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	With the first readouts of trials of antibodies against COVID-19 appearing and others coming thick and fast, Nature Biotechnology asked a group of experts to comment on the challenges and timelines for these products.
ISSN:	1087-0156 1546-1696
DOI:	10.1038/s41587-020-0732-8